Health innovation and health equity: Ensuring technologies advance resilience, justice, and compassionate care

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Technological innovations are often hailed as transformative tools capable of revolutionizing healthcare. From gene editing for conditions like sickle cell disease to AI predicting hospital readmissions, to telemedicine expanding healthcare access, these advancements have the potential to change the way we treat diseases. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Jamillah Hoy-Rosas, MPH, RD, CDCES
Head of population health and healthcare experience, Ronald McDonald House, New York
Table of Contents

YOU MAY BE INTERESTED IN

At the 2026 Annual Meeting of the American Society of Clinical Oncology in Chicago, results from the phase III HARMONi-6 trial were presented at the plenary session and published simultaneously in The Lancet. The HARMONi-6 trial tested a novel bispecific antibody that engages PD-1 and VEGF (ivonescimab), given with platinum-doublet chemotherapy to patients with previously untreated advanced squamous non-small cell lung cancer. 
In 2026, more than 900 million people are estimated to be regularly using generative artificial intelligence—computer systems capable of creating human-like text, images, audio, video, and other original content. AI is becoming integrated into nearly every aspect of daily life. Health care is no exception. 
Jamillah Hoy-Rosas, MPH, RD, CDCES
Head of population health and healthcare experience, Ronald McDonald House, New York

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login